EVERSANA, the leading independent provider of global services to the life science industry, is proud to join the rare disease community as a sponsor of Global Genes’ RARE in the Square, which connects rare disease stakeholders as they strive to eliminate the challenges of rare disease.
RARE in the Square coincides with the JP Morgan Healthcare Conference in San Francisco, California, January 7. Investors, industry partners, patient community leaders and influencers — all who share a commitment to helping the more than 350 million people impacted by rare disease — will gather to collaborate about innovation and therapeutics.
“We share Global Genes’ pursuit of building better lives for patients with rare disease,” shared Kathi Henson, Patient Services President, EVERSANA. “Our integrated platform is building stronger patient relationships, increasing adherence, and supporting healthier outcomes for the millions living with rare diseases.”
EVERSANA provides a unique wrap-around patient-service model for patients with rare disease, guiding them every step of the way. Our dedicated team helps support a faster onboarding process, identifies affordability solutions, and drives the highest possible adherence for our patients– all through a single point of contact.
EVERSANA is proud to support Global Genes’ mission to connect, empower, and inspire the rare disease community — a mission we share. To date, Global Genes has educated 6 million people in 100 countries about rare disease, equipped 30,000 patients and advocates with tools and resources, and provided $400,000 in support for innovative patient impact programs.